Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Endothelial progenitor cells in diabetic foot syndrome.

Drela E, Stankowska K, Kulwas A, Rość D.

Adv Clin Exp Med. 2012 Mar-Apr;21(2):249-54. Review.

2.

Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels.

Bauer SM, Bauer RJ, Liu ZJ, Chen H, Goldstein L, Velazquez OC.

J Vasc Surg. 2005 Apr;41(4):699-707.

3.

Hyperbaric oxygen and bone marrow-derived endothelial progenitor cells in diabetic wound healing.

Gallagher KA, Goldstein LJ, Thom SR, Velazquez OC.

Vascular. 2006 Nov-Dec;14(6):328-37. Review.

PMID:
17150153
4.

Insulin modulates ischemia-induced endothelial progenitor cell mobilization and neovascularization in diabetic mice.

Dong L, Kang L, Ding L, Chen Q, Bai J, Gu R, Li L, Xu B.

Microvasc Res. 2011 Nov;82(3):227-36. doi: 10.1016/j.mvr.2011.09.006. Epub 2011 Sep 21.

PMID:
21964072
5.

Decreased mobilization of endothelial progenitor cells contributes to impaired neovascularization in diabetes.

Kang L, Chen Q, Wang L, Gao L, Meng K, Chen J, Ferro A, Xu B.

Clin Exp Pharmacol Physiol. 2009 Oct;36(10):e47-56. doi: 10.1111/j.1440-1681.2009.05219.x. Epub 2009 Jun 16.

PMID:
19558529
6.

Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.

Yu JX, Huang XF, Lv WM, Ye CS, Peng XZ, Zhang H, Xiao LB, Wang SM.

J Vasc Surg. 2009 Sep;50(3):608-16. doi: 10.1016/j.jvs.2009.05.049. Epub 2009 Jul 12.

7.

Endothelial progenitor cells as a new agent contributing to vascular repair.

Miller-Kasprzak E, Jagodziński PP.

Arch Immunol Ther Exp (Warsz). 2007 Jul-Aug;55(4):247-59. Epub 2007 Jul 23. Review.

PMID:
17659378
8.

Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy.

Liu X, Li Y, Liu Y, Luo Y, Wang D, Annex BH, Goldschmidt-Clermont PJ.

Am J Pathol. 2010 Jan;176(1):504-15. doi: 10.2353/ajpath.2010.081152. Epub 2009 Nov 30.

9.

Mobilization of endothelial progenitor cells in fracture healing and distraction osteogenesis.

Lee DY, Cho TJ, Kim JA, Lee HR, Yoo WJ, Chung CY, Choi IH.

Bone. 2008 May;42(5):932-41. doi: 10.1016/j.bone.2008.01.007. Epub 2008 Jan 26.

PMID:
18326482
10.

Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha.

Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG, Nedeau A, Thom SR, Velazquez OC.

J Clin Invest. 2007 May;117(5):1249-59.

11.
12.

Challenges in vascular repair by endothelial progenitor cells in diabetic patients.

António N, Fernandes R, Ribeiro CF, Providência LA.

Cardiovasc Hematol Disord Drug Targets. 2010 Sep 1;10(3):161-6. Review.

PMID:
20678063
13.

Fracture induced mobilization and incorporation of bone marrow-derived endothelial progenitor cells for bone healing.

Matsumoto T, Mifune Y, Kawamoto A, Kuroda R, Shoji T, Iwasaki H, Suzuki T, Oyamada A, Horii M, Yokoyama A, Nishimura H, Lee SY, Miwa M, Doita M, Kurosaka M, Asahara T.

J Cell Physiol. 2008 Apr;215(1):234-42. doi: 10.1002/jcp.21309.

PMID:
18205179
14.

Mobilization, endothelial differentiation and functional capacity of endothelial progenitor cells after ischemic stroke.

Navarro-Sobrino M, Rosell A, Hernandez-Guillamon M, Penalba A, Ribó M, Alvarez-Sabín J, Montaner J.

Microvasc Res. 2010 Dec;80(3):317-23. doi: 10.1016/j.mvr.2010.05.008. Epub 2010 Jun 4.

PMID:
20594997
15.

The bone marrow-derived endothelial progenitor cell response is impaired in delayed wound healing from ischemia.

Bauer SM, Goldstein LJ, Bauer RJ, Chen H, Putt M, Velazquez OC.

J Vasc Surg. 2006 Jan;43(1):134-41.

16.

Transplantation of endothelial progenitor cells transferred by vascular endothelial growth factor gene for vascular regeneration of ischemic flaps.

Yi C, Xia W, Zheng Y, Zhang L, Shu M, Liang J, Han Y, Guo S.

J Surg Res. 2006 Sep;135(1):100-6. Epub 2006 Mar 29.

PMID:
16566941
17.

Human cord blood-derived endothelial progenitor cells and their conditioned media exhibit therapeutic equivalence for diabetic wound healing.

Kim JY, Song SH, Kim KL, Ko JJ, Im JE, Yie SW, Ahn YK, Kim DK, Suh W.

Cell Transplant. 2010;19(12):1635-44. doi: 10.3727/096368910X516637. Epub 2010 Jul 15.

PMID:
20659357
18.

Cellular and molecular basis of wound healing in diabetes.

Brem H, Tomic-Canic M.

J Clin Invest. 2007 May;117(5):1219-22. Review.

19.

Type 2 diabetes mellitus impairs the maturation of endothelial progenitor cells and increases the number of circulating endothelial cells in peripheral blood.

Lombardo MF, Iacopino P, Cuzzola M, Spiniello E, Garreffa C, Ferrelli F, Coppola A, Saccardi R, Piaggesi A, Piro R, Mannino D, Grossi G, Lauro D, Irrera G.

Cytometry A. 2012 Oct;81(10):856-64. doi: 10.1002/cyto.a.22109. Epub 2012 Aug 28.

20.

Topical application of ex vivo expanded endothelial progenitor cells promotes vascularisation and wound healing in diabetic mice.

Asai J, Takenaka H, Ii M, Asahi M, Kishimoto S, Katoh N, Losordo DW.

Int Wound J. 2013 Oct;10(5):527-33. doi: 10.1111/j.1742-481X.2012.01010.x. Epub 2012 Jun 28.

PMID:
22738265
Items per page

Supplemental Content

Write to the Help Desk